Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

Phase 1

5(38.5%)

N/A

3(23.1%)

Phase 2

3(23.1%)

Phase 3

2(15.4%)

13Total

Phase 1(5)

N/A(3)

Phase 2(3)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials

NCT07415304Phase 1Not Yet Recruiting

A Phase 1 Study of ISM4808 in Healthy Adult Subjects

Role: collaborator

NCT01944774Phase 2Completed

Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride

Role: collaborator

NCT05552781Phase 1Recruiting

H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC

Role: collaborator

NCT06243640Phase 3Recruiting

Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD

Role: collaborator

NCT06243614Phase 3Recruiting

Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD

Role: collaborator

NCT02962297Not ApplicableCompleted

Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis

Role: collaborator

NCT04706468Phase 2Completed

To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection

Role: collaborator

NCT03756103Phase 2Completed

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Role: collaborator

NCT04495322Phase 1Completed

To Evaluate the Safety, Tolerability, and Pharmacokinetics Profiles of TG-1000 in Healthy Volunteers, and the Food Effect on Pharmacokinetics of Single Oral Dose of TG-1000 in Healthy Volunteers.

Role: collaborator

NCT02944890Not ApplicableCompleted

Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis

Role: collaborator

NCT02946307Not ApplicableCompleted

Assess the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease

Role: collaborator

NCT03610867Phase 1Completed

To Evaluate the Safety, Tolerability, and Pharmacokinetics Profile in Healthy Chinese Volunteers of TG-2349

Role: collaborator

NCT03610880Phase 1Completed

To Evaluate PK and Safety Profile of Oral MAD of Separately Using TG-2349, DAG181 or Combination in Healthy Chinese Volunteers

Role: collaborator

All 13 trials loaded